Doğukan YILMAZ, Ali Orkun TOPÇU, Emine Ülke AKÇAY, Ali TAMER, MUSTAFA ALTINDİŞ

Periodontitis ve tip 2 diyabetli bireylerdeki glisemik kontrolün salya antimikrobiyal peptid seviyesine olan etkisinin incelenmesi

Amaç: İnsan beta-defensinler (hBD) ve kathelisin (LL-37) homeostazın sağlanmasında önemli ve çoklu görevler alırlar. Oral ve periodontal doku ve sıvılarda, Tip 2 Diabetes Mellitus (T2DM) ile bu peptidler arasındaki ilişki net değildir. Çalışmamızın amacı, T2DM’li bireylerde glisemik kontrol seviyesinin, salya hBD ve LL-37 konsantrasyonu üzerine olan etkisinin incelenmesidir. Gereç ve Yöntem: Çalışmaya 178 birey dahil edilmiştir. Demografik veriler, dental ve medikal geçmişler sözlü olarak elde edilmiştir. Glisemik kontrol seviyeleri için açlık kan şekeri ve glikolize hemoglobin (HbA1c) değerleri ölçülmüştür. Tüm ağız periodontal indeks değerleri ölçülerek panaromik filmler yardımıyla periodontal teşhisler yapılmıştır. Bireylerden stimüle olmayan yöntemle salya örnekleri toplanmış ve ELISA tekniği ile salya hBD -1, -2, -3, LL-37 ve ileri glikolizasyon son ürünü (AGE) değerleri ölçülmüştür. Bulgular: Dişeti sağlıklı bireylerden oluşan gruplar arasında ve kontrollü T2DM bireylerin salya hBD seviyelerinin diğer gruplara oranla anlamlı derecede yüksek olduğu tespit edilmiştir. (p

The effect of glycemic control on salivary antimicrobial peptide levels in patients with periodontitis and type 2 diabetes mellitus

Aim: The purpose of this study was to evaluate the dentists’ knowledge, attitude and behaviour regarding dental trauma in Rize Province. Materials and Methods: Total of 121 dentists, 73 females and 48 males, were included in this study. A questionnaire consisted of 34 questions and three sections was applied face to face. Personal and professional knowledge and attitudes about dental trauma were evaluated. The association between the dentists at different education level and trauma intervention were analyzed with chi-square test. Results: Most of general dentists (48.1%), postgraduate students (69.6%) and specialists (53.3%) preferred composite, fiber and ligature wire as splint materials, respectively (p

PDF

___

1. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018. American Diabetes Association. Diabetes Care 2018; 41: 13-27.
2. Casanova L, Hughes FJ, Preshaw PM. Diabetes and periodontal disease: a two-way relationship. Br Dent J 2014; 217: 433-437.
3. Byun K, Yoo Y, Son M, Lee J, Jeong GB et al. Advanced glycation end-products produced systemically and by macrophages: A common contributor to inflammation and degenerative diseases. Pharmacol Ther 2017; 177: 44-55.
4. Taylor JJ, Preshaw PM, Lalla E. A review of the evidence for pathogenic mechanisms that may link periodontitis and diabetes. J Periodontol 2013; 84: 113-134.
5. Piperi C, Goumenos A, Adamopoulos C, Papavassiliou AG. AGE/RAGE signalling regulation by miRNAs: associations with diabetic complications and therapeutic potential. Int J Biochem Cell Biol 2015; 60: 197-201.
6. Kocher T, König J, Borgnakke WS, Pink C, Meisel P. Periodontal complications of hyperglycemia/diabetes mellitus: Epidemiologic complexity and clinical challenge. Periodontol 2000 2018; 78: 59-97.
7. Tsai C, Hayes C, Taylor GW. Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population. Community Dent Oral Epidemiol 2002; 30: 182-192.
8. Groeger SE, Meyle J. Epithelial barrier and oral bacteri
9. Gupta S, Bhatia G, Sharma A, Saxena S. Host defense peptides: An insight into the antimicrobial world. J Oral Maxillofac Pathol 2018; 22: 239-244.
10. Gomes Pde S, Fernandes MH. Defensins in the oral cavity: distribution and biological role. J Oral Pathol Med 2010; 39: 1-9.
11. Güncü GN, Yilmaz D, Könönen E, Gürsoy UK. Salivary Antimicrobial Peptides in Early Detection of Periodontitis. Front Cell Infect Microbiol 2015; 24: 5-9.
12. Yang D, Liu ZH, Tewary P, Chen Q, de la Rosa G et al. Defensin participation in innate and adaptive immunity. Curr Pharm Des 2007; 13: 3131-3139.
13. Gursoy UK, Könönen E. Understanding the roles of gingival beta-defensins. J Oral Microbiol 2012; 4.
14. Yılmaz D, Güncü GN, Könönen E, Barış E, Çağlayan F et al. Overexpressions of hBD-2, hBD-3, and hCAP18/LL37 in Gingiva of Diabetics with Periodontitis. Immunobiol 2015; 220: 1219-1226.
15. Yilmaz D, Caglayan F, Buber E, Könönen E, Aksoy Y et al. Gingival crevicular fluid levels of human beta-defensin-1 in type 2 diabetes mellitus and periodontitis. Clin Oral Investig 2018; 22: 2135-2140.
16. Ertugrul AS, Dikilitas A, Sahin H, Alpaslan N, Bozoglan A et al. Gingival crevicular fluid levels of human beta-defensins 1 and 3 in subjects with periodontitis and/or type 2 diabetes mellitus: a cross-sectional study. J Periodontal Res 2013; 48: 475-482.
17. Lan CC, Wu CS, Huang SM, Kuo HY, Wu IH et al. High-glucose environment reduces human β-defensin-2 expression in human keratinocytes: implications for poor diabetic wound healing. Br J Dermatol 2012; 166: 12211229.
18. Silness, J, Löe H. Periodontal disease in pregnancy II. correlation between oral hygiene and periodontal condition. Acta Odontol. Scand 1964; 22: 121-135.
19. Löe H, Silness J. Periodontal disease in pregnancy. I. prevalence and severity. Acta Odontol. Scand 1963; 21: 533-551.
20. Papapanou PN, Sanz M, Buduneli N, Dietrich T, Feres M et al. Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Periodontol 2018; 89: 173-182.
21. Dommisch H, Skora P, Hirschfeld J, Olk G, Hildebrandt L et al. The guardians of the periodontium-sequential and differential expression of antimicrobial peptides during gingival inflammation. Results from in vivo and in vitro studies. J Clin Periodontol 2019; 46: 276-285.
22. Offenbacher S, Barros SP, Paquette DW, Winston JL, Biesbrock AR et al. Gingival transcriptome patterns during induction and resolution of experimental gingivitis in humans. J Periodontol 2009; 80: 1963-1982.
23. Pereira AL, Franco GC, Cortelli SC, Aquino DR, Costa FO et al. Influence of periodontal status and periodontopathogens on levels of oral human β-defensin-2 in saliva. J Periodontol 2013; 84: 1445-1453.
24. Li S, Schmalz G, Schmidt J, Krause F, Haak R, et al. Antimicrobial peptides as a possible interlink between periodontal diseases and its risk factors: A systematic review. J Periodontal Res 2018; 53: 145-155.
25. Montoya-Rosales A, Castro-Garcia P, Torres-Juarez F, Enciso-Moreno JA, Rivas-Santiago B. Glucose levels affect LL-37 expression in monocyte-derived macrophages altering the Mycobacterium tuberculosis intracellular growth control. Microb Pathog 2016; 97: 148-153.
26. Rivas-Santiago B, Trujillo V, Montoya A, Gonzalez-Curiel I, Castañeda-Delgado J et al. Expression of antimicrobial peptides in diabetic foot ulcer. Dermatol Sci 2012; 65: 19-26.
27. Svensson D, Wilk L, Mörgelin M, Herwald H, Nilsson BO. LL-37-induced host cell cytotoxicity depends on cellular expression of the globular C1q receptor (p33). Biochem J 2016; 473: 87-98.
28. Yeh CH, Sturgis L, Haidacher J, Zhang XN, Sherwood SJ et al. Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion. Diabetes 2001; 50: 1495-1504.
29. Hu H, Jiang H, Ren H, Hu X, Wang X et al. AGEs and chronic subclinical inflammation in diabetes: disorders of immune system. Diabetes Metab Res Rev 2015; 31: 127137.
30. Bloomgarden ZT, Handelsman Y. Approaches to treatment 2:Comparison of American Association of Clinical Endocrinologists (AACE) and American Diabetes Association (ADA) type 2 diabetes treatment guidelines. J Diabetes 2016; 8: 4-6.
31. Barnea M, Madar Z, Froy O. Glucose and insulin are needed for optimal defensin expression in human cell lines. Biochem Biophys Res Commun 2008; 367: 452-456.